448 related articles for article (PubMed ID: 34727201)
1. The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial.
Sangouni AA; Pakravanfar F; Ghadiri-Anari A; Nadjarzadeh A; Fallahzadeh H; Hosseinzadeh M
Eur J Nutr; 2022 Apr; 61(3):1199-1207. PubMed ID: 34727201
[TBL] [Abstract][Full Text] [Related]
2. Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight/obese women with polycystic ovary syndrome: A randomized controlled trial.
Sangouni AA; Sasanfar B; Ghadiri-Anari A; Hosseinzadeh M
Clin Nutr ESPEN; 2021 Dec; 46():54-59. PubMed ID: 34857248
[TBL] [Abstract][Full Text] [Related]
3. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
4. Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
Jamilian M; Foroozanfard F; Kavossian E; Kia M; Aghadavod E; Amirani E; Asemi Z
Biol Trace Elem Res; 2020 Feb; 193(2):334-341. PubMed ID: 30977089
[TBL] [Abstract][Full Text] [Related]
5. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Samimi M; Jamilian M; Ebrahimi FA; Rahimi M; Tajbakhsh B; Asemi Z
Clin Endocrinol (Oxf); 2016 Jun; 84(6):851-7. PubMed ID: 26666519
[TBL] [Abstract][Full Text] [Related]
6. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
7. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
Zhang J; Xing C; Cheng X; He B
Front Endocrinol (Lausanne); 2022; 13():1003238. PubMed ID: 36147577
[TBL] [Abstract][Full Text] [Related]
8. The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.
Tabrizi FPF; Farhangi MA; Vaezi M; Hemmati S
Nutr J; 2020 Aug; 19(1):82. PubMed ID: 32782010
[TBL] [Abstract][Full Text] [Related]
9. Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
Asemi Z; Karamali M; Esmaillzadeh A
Mol Nutr Food Res; 2014 Jul; 58(7):1465-73. PubMed ID: 24828019
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Qorbani M; Sanginabadi M; Mohajeri-Tehrani MR; Karimi S; Gerami H; Mahdavi-Gorabi A; Shirzad N; Samadi M; Baygi F; Hosseini S; Mansour A
Front Endocrinol (Lausanne); 2020; 11():590392. PubMed ID: 33408691
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
12. The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome.
Khorshidi M; Moini A; Alipoor E; Rezvan N; Gorgani-Firuzjaee S; Yaseri M; Hosseinzadeh-Attar MJ
Phytother Res; 2018 Nov; 32(11):2282-2289. PubMed ID: 30062709
[TBL] [Abstract][Full Text] [Related]
13. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Efficacy of Sex Hormone-Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS.
Chen F; Liao Y; Chen M; Yin H; Chen G; Huang Q; Chen L; Yang X; Zhang W; Wang P; Yin G
Reprod Sci; 2021 Sep; 28(9):2504-2513. PubMed ID: 33721297
[TBL] [Abstract][Full Text] [Related]
15. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
Menichini D; Facchinetti F
Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
[TBL] [Abstract][Full Text] [Related]
17. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial.
Sohaei S; Amani R; Tarrahi MJ; Ghasemi-Tehrani H
Complement Ther Med; 2019 Dec; 47():102201. PubMed ID: 31780025
[TBL] [Abstract][Full Text] [Related]
18. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
Jamilian M; Foroozanfard F; Rahmani E; Talebi M; Bahmani F; Asemi Z
Nutrients; 2017 Nov; 9(12):. PubMed ID: 29186759
[TBL] [Abstract][Full Text] [Related]
19. Adding L-carnitine to antagonist ovarian stimulation doesn't improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: a double-blind randomized clinical trial.
Hafezi M; Arabipoor A; Ghaffari F; Vesali S; Zareei M; Hessari ZH
J Ovarian Res; 2024 Jan; 17(1):9. PubMed ID: 38191449
[TBL] [Abstract][Full Text] [Related]
20. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
